ArticleBiologics : targets & therapy2026

Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review.

Olena Garmish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.